Federal appeals court to consider Louisiana’s arguments for banning telehealth abortion
The case could affect telehealth access nationwide, with about 91,000 abortions last year linked to mail prescriptions in ban states, Guttmacher Institute said.
- On Wednesday, the U.S. Fifth Circuit Court of Appeals will hear arguments regarding Louisiana's challenge to telehealth abortion access, seeking to overturn federal rules permitting abortion pills prescribed without in-person visits.
- Louisiana officials argue the 2023 Food and Drug Administration rule allowing mail-order abortion pills violates the 2022 Supreme Court ruling in Dobbs v. Jackson Women's Health Organization, which returned abortion regulation to states.
- According to Guttmacher Institute, about 91,000 abortions were provided last year via telehealth prescriptions, including more than 9,300 in Louisiana; Alliance Defending Freedom counsel Gabriella McIntyre expects a favorable ruling.
- Abortion law expert Mary Ziegler expects the conservative Fifth Circuit to side with Louisiana, noting the ruling will likely serve as a roadmap for the U.S. Supreme Court's future deliberations.
- Pressure from anti-abortion policymakers continues as the FDA conducts a safety review of mifepristone as part of broader efforts to restrict access nationwide.
15 Articles
15 Articles
Federal court to hear arguments on abortion pill access
Click in for more news from The Hill {beacon} Healthcare Healthcare The Big Story Federal court to hear arguments on abortion pill access A three-judge panel on the 5th U.S. Circuit Court of Appeals in New Orleans will hear arguments Wednesday in a case that could eventually restrict the nationwide distribution of the abortion…
Louisiana et al. v. Food and Drug Administration: A case working its way through federal courts poses a dangerous threat to abortion access nationwide.
A significant case1 currently progressing through federal courts poses one of the most formidable threats to abortion access since the overturning of Roe v. Wade. In Louisiana et al. v. Food and Drug Administration, Louisiana seeks to impose its anti-abortion policies on states nationwide, and the outcome of this case may dictate whether individuals can access […]
Federal appeals court to consider Louisiana’s arguments for banning telehealth abortion • Oklahoma Voice
Next week, the U.S. 5th Circuit Court of Appeals will consider Louisiana’s arguments for tightening federal policy around a common abortion and miscarriage drug. The primary target of Louisiana v. Food and Drug Administration and similar lawsuits against mifepristone is to end a Biden-era policy allowing abortion pills to be prescribed without an in-person visit with a provider.
Coverage Details
Bias Distribution
- 87% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
